Ultrasound Imaging to Validate I-gel Placement in pediatrıc Patients
Comparison of Fiberoptic Bronchoscopy and Ultrasound Imaging to Validate I-gel Placement in Pediatric Patients
1 other identifier
observational
110
1 country
1
Brief Summary
For nearly half a century, supraglottic airway devices (SGA) have been used in pediatric patients, which are more practical than face masks, facilitate oxygenation and ventilation without the need for endotracheal intubation, and less invasive than endotracheal tubes. I-Gel is a supraglottic airway management device introduced in 2007, made of a medical grade thermoplastic elastomer, designed to create a non-inflatable, anatomical seal in the pharyngeal, laryngeal and perilaryngeal structures that prevents compression trauma. Recently, the use of I-Gel has become popular in children undergoing surgery that does not require muscle relaxation. It is important to place an I-Gel in the most appropriate position in order to provide adequate ventilation and prevent complications such as mucosal injury, glottic ptosis, and gastric insufflation with potential aspiration. Successful placement is usually clinically assessed by a capnogram with endtidal carbon dioxide (ETCO2) value, visual examination and auscultation with appropriate chest elevation, absence of oropharyngeal leakage at 20 cm H2O peak inspiratory pressure. Although Fiberoptic Bronchoscope (FOB) is accepted as the preferred verification tool for direct visualization, some studies on I-Gel position using FOB reported that I-Gel placement should be repositioned in some children (12.8-49%). Ultrasonography (USG), which has recently entered the practice of upper airway examination, has become a valuable, non-invasive, simple and portable technology for evaluating airway management even in upper airway anatomy impaired by pathology or trauma. The aim of this study is to compare the use of USG with the FOB to evaluate I-Gel placement in pediatric patients. The primary endpoint is to compare the incidence of for I-Gel malposition between USG and FOB. Secondary endpoints are to find the correlation between I-Gel's USG and FOB-detected malposition and to determine the diagnostic performance of the USG.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2020
CompletedFirst Posted
Study publicly available on registry
December 3, 2020
CompletedStudy Start
First participant enrolled
December 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2021
CompletedDecember 3, 2020
November 1, 2020
2 months
November 26, 2020
November 26, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
the incidence of for I-Gel malposition between USG and FOB
to compare the incidence of for I-Gel malposition between USG and FOB.
1 months
Secondary Outcomes (1)
the correlation between I-Gel's USG and FOB
1 months
Interventions
To compare the incidence of for I-Gel malposition between USG and FOB, and to find the correlation between I-Gel's USG and FOB-detected malposition
Eligibility Criteria
The pediatric patients who were scheduled to undergo surgery under general anesthesia placed I-Gel for airway were enrolled in the study.
You may qualify if:
- Undergoing elective pediatric surgery
- American Society of Anesthesiologists (ASA) status I-II
- Placed I-Gel for airway
You may not qualify if:
- Patients with head and neck anatomical malformation and airway congenital defects
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Selcuk University, School of Medicine
Konya, 42250, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Faruk Cicekci
Selcuk University, School of Medicine, Department of Anesthesiology and Intensive Care
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
November 26, 2020
First Posted
December 3, 2020
Study Start
December 15, 2020
Primary Completion
January 30, 2021
Study Completion
February 15, 2021
Last Updated
December 3, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share